Free Trial
NASDAQ:CLVR

Clever Leaves (CLVR) Stock Price, News & Analysis

Clever Leaves logo

About Clever Leaves Stock (NASDAQ:CLVR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1 shs
Average Volume
1,746 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter.

CLVR Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Clever Leaves Holdings Inc.
See More Headlines

CLVR Stock Analysis - Frequently Asked Questions

Shares of Clever Leaves reverse split before market open on Friday, August 25th 2023.The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clever Leaves investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Advanced Micro Devices (AMD) and Salesforce (CRM).

Company Calendar

Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CLVR
Fax
N/A
Employees
560
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$17.42 million
Price / Cash Flow
N/A
Book Value
$14.02 per share
Price / Book
N/A

Miscellaneous

Free Float
1,611,000
Optionable
No Data
Beta
3,440.04
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:CLVR) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners